These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7284265)

  • 21. Dithranol (anthralin) versus triacetoxyanthracene. Investigations in vitro.
    Raab W
    Br J Dermatol; 1976 Aug; 95(2):193-6. PubMed ID: 782506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calorimetric and manometric measurements on human skin fibroblasts in culture.
    Pätel M; Schaarschmidt B; Reichert U
    Br J Dermatol; 1981 Aug; 105 Suppl 20():60-1. PubMed ID: 7284268
    [No Abstract]   [Full Text] [Related]  

  • 23. [The cytotoxic and antimutagenic effect of dithranol].
    Bernd A; Holzmann H; Kurelec B; Britivic S; Müller WE
    Dermatol Monatsschr; 1989; 175(5):261-7. PubMed ID: 2744194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of epidermal proliferation by ultraviolet light, coal tar and anthralin.
    Walter JF; Stoughton RB; DeQuoy PR
    Br J Dermatol; 1978 Jul; 99(1):89-96. PubMed ID: 678469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of metabolic cooperation is associated with the tumor promoters, oleic acid and anthralin.
    Trosko JE; Jone C; Aylsworth C; Tsushimoto G
    Carcinogenesis; 1982; 3(9):1101-3. PubMed ID: 7139869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of soybean lipoxygenase-1 by 10-butyryl substituted 1,8-dihydroxy-9-anthrone (butantrone).
    Laakso S; Römer L; Mustakallio KK
    Med Biol; 1986; 64(1):43-5. PubMed ID: 3088340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A microspectrofluorometric study of the effect of anthralin, an antipsoriatic drug, on cellular structures and metabolism.
    Kohen E; Kohen C; Morliere P; Santus R; Reyftmann JP; Dubertret L; Hirschberg JG; Coulomb B
    Cell Biochem Funct; 1986 Jul; 4(3):157-68. PubMed ID: 3731395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical effect of anthralin on 12-O-tetradecanoylphorbol-13-acetate-induced mouse epidermal ornithine decarboxylase activity, proliferation, and tumor promotion.
    De Young LM; Helmes CT; Chao WR; Young JM; Miller V
    Cancer Res; 1981 Jan; 41(1):204-8. PubMed ID: 7448761
    [No Abstract]   [Full Text] [Related]  

  • 29. Ingram method: the precursor of photochemotherapy.
    Raab WP
    Br J Dermatol; 1981 Aug; 105 Suppl 20():77-81. PubMed ID: 7284273
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of human monocyte functions by anthralin.
    Mrowietz U; Falsafi M; Schröder JM; Christophers E
    Br J Dermatol; 1992 Oct; 127(4):382-6. PubMed ID: 1329912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an antipsoriatic agent, dithranol, on mitochondrial and nuclear functions in yeast cells.
    Zetterberg G
    Hereditas; 1977; 86(2):191-204. PubMed ID: 334708
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure and tumor-promoting activity of anthralin (1,8-dihydroxy-9-anthrone) and related compounds.
    Segal A; Katz C; Van Duuren BL
    J Med Chem; 1971 Dec; 14(12):1152-4. PubMed ID: 5116226
    [No Abstract]   [Full Text] [Related]  

  • 33. Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition.
    Cavey D; Caron JC; Shroot B
    Br J Dermatol; 1981 Aug; 105 Suppl 20():15-9. PubMed ID: 7284258
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of dithranol on epidermal proliferation by urea modification].
    Wohlrab W
    Dermatol Monatsschr; 1985; 171(2):85-90. PubMed ID: 3979627
    [No Abstract]   [Full Text] [Related]  

  • 35. Site variation in anthralin inflammation on forearm skin.
    Lawrence CM; Howel D; Shuster S
    Br J Dermatol; 1986 May; 114(5):609-13. PubMed ID: 3718851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the live cell DNA marker DRAQ5 on chromatin-associated processes.
    Mari PO; Verbiest V; Sabbioneda S; Gourdin AM; Wijgers N; Dinant C; Lehmann AR; Vermeulen W; Giglia-Mari G
    DNA Repair (Amst); 2010 Jul; 9(7):848-55. PubMed ID: 20439168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the mode of action of dithranol: increased lipid peroxidation and enzyme inhibition].
    Diezel W; Meffert H; Sönnichsen N
    Dermatologica; 1975; 150(3):154-62. PubMed ID: 125665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect on epidermal DNA synthesis of a combination of topical steroid with either dithranol or tar as used for psoriasis.
    Clement M; Hehir M; Phillips H; du Vivier A
    Br J Dermatol; 1983 Sep; 109(3):327-35. PubMed ID: 6615719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Side effects of anthralin and its 2 main impurities on healthy skin].
    Puschmann M; Schmersahl P
    Z Hautkr; 1983 Mar; 58(6):410-6. PubMed ID: 6857758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin.
    Czernielewski J; Juhlin L; Shroot S; Brun P
    Acta Derm Venereol; 1985; 65(2):97-101. PubMed ID: 2408430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.